[{"NetIncomeLoss_1_Q3_USD":7771000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"AccruedRoyaltiesCurrent_0_Q3_USD":6061000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q3_USD":33000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":902000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":111000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-50698000.0,"Depreciation_3_Q3_USD":1026000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":32000.0,"IncomeTaxReconciliationOtherReconcilingItems_3_Q3_USD":200000.0,"IncomeTaxReconciliationOtherReconcilingItems_1_Q3_USD":100000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_3_Q3_USD":-102000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_1_Q3_USD":33000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":31820000.0,"AssetsCurrent_0_Q3_USD":461808000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":1299000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-1222000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":315187000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":90600000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":32456000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":2194547.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":2233806.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":371000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":264907000.0,"CommonStockSharesIssued_0_Q3_shares":55708730.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":355446000.0,"Liabilities_0_Q3_USD":86446000.0,"Assets_0_Q3_USD":579767000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":664408000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":50522000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q3_USD":6797000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":56032000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":19653000.0,"EarningsPerShareBasic_1_Q3_USD":0.14,"EarningsPerShareBasic_3_Q3_USD":0.47,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":10000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":56818295.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":57040736.0,"AssetsFairValueDisclosure_0_Q3_USD":355446000.0,"AccountsReceivableNetCurrent_0_Q3_USD":41496000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":7680000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":2951000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-1451000.0,"CommonStockValue_0_Q3_USD":56000.0,"Revenues_3_Q3_USD":200663000.0,"Revenues_1_Q3_USD":70095000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":860000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":2509000.0,"CostsAndExpenses_3_Q3_USD":167134000.0,"CostsAndExpenses_1_Q3_USD":59276000.0,"IncreaseDecreaseInInventories_3_Q3_USD":2156000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":12000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":25946000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":7779000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1109000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":370000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0075,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":10457000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-128000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":8000.0,"ShareBasedCompensation_3_Q3_USD":11600000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-171254000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-10572000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":11484000.0,"CommonStockSharesOutstanding_0_Q3_shares":55708730.0,"EarningsPerShareDiluted_1_Q3_USD":0.14,"EarningsPerShareDiluted_3_Q3_USD":0.46,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":135000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":33754000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":10722000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3951000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":37607000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":55668156.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":55467528.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_3_Q3_pure":0.46,"LiabilitiesCurrent_0_Q3_USD":71997000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":51041000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":13442000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2509000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":1350767.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":1372580.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q3_USD":78000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":20450000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"InventoryNoncurrent_0_Q3_USD":7281000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":3318000.0,"NetIncomeLoss_3_Q3_USD":26074000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":355343000.0,"OtherIncome_1_Q3_USD":-97000.0,"OtherIncome_3_Q3_USD":225000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":418000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":9580000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q3_USD":76105000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":8.91,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2932000.0,"OtherComprehensiveIncomeLossTax_3_Q3_USD":-22000.0,"OtherComprehensiveIncomeLossTax_1_Q3_USD":8000.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":200663000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":70095000.0,"OperatingIncomeLoss_3_Q3_USD":33529000.0,"OperatingIncomeLoss_1_Q3_USD":10819000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_3_Q3_USD":19393000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_3_Q3_USD":-48000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":355446000.0,"InventoryNet_0_Q3_USD":902000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"PreferredStockValue_0_Q3_USD":0.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":5432000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":579767000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5434000.0,"PreferredStockSharesAuthorized_0_Q3_shares":20000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":11600000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3951000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2295000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3992000.0,"StockholdersEquity_0_Q3_USD":493321000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q3_USD":-17000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":7371000.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]